Ellsworth Advisors »

Supernus Pharmaceuticals shares owned by Ellsworth Advisors

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Ellsworth Advisors from 13F filings

Historical chart of Ellsworth Advisors investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Ellsworth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Ellsworth Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $871k 17k 51.69

More positions owned by Ellsworth Advisors

Spdr Gold Tr Gold Shs (GLD)
Harbor Etf Trust Harbor Commodity (HGER)
NVIDIA Corporation (NVDA)
First Tr Exchange-traded First Tr Enh New (FTSM)
Johnson & Johnson (JNJ)
Apple (AAPL)
Amgen (AMGN)
Enterprise Products Partners (EPD)
Chevron Corporation (CVX)
Alphabet Cap Stk Cl C (GOOG)
Petroleo Brasileiro S A Sponsored Adr (PBR)
Vertiv Holdings Com Cl A (VRT)
Eli Lilly & Co. (LLY)
Altria (MO)
Pepsi (PEP)

View all positions for Ellsworth Advisors

Top funds holding Supernus Pharmaceuticals

BlackRock
Vanguard Group
Millennium Management
Vanguard Portfolio Management
Vanguard Capital Management
Dimensional Fund Advisors
State Street Corporation
Nomura Asset Management International
Armistice Capital
Renaissance Technologies
Geode Capital Management
Citadel Advisors
Loomis, Sayles and
Stephens Investment Management Group
Point72 Asset Management

View all funds holding Supernus Pharmaceuticals